Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Peritoneal Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms 1Fallopian Tube Neoplasms 1Fallopian Tube Diseases 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tissue Banks × Gynecologic × Clear all
NCT02973750 2023-01-26

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

H. Lee Moffitt Cancer Center and Research Institute

Completed
20 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡